The value of tracheostomy was assessed for each patient in relation to the subsequent progress of the underlying disease, to complications of the tracheostomy, and to mortality. Three grades of value were distinguished: (1) the patient would have died had tracheostomy not been performed-211 (54%);
(2) the tracheostomy was of definite value to the patient and contributed materially to recovery, even if death eventually occurred as a result of the underlying disease-105 (27%) ; and (3) tracheostomy was of no value in that the patient died as a result of a complication of that procedure, or the complication was a closely related cause of death, or, more usually, tracheostomy was carried out on an already moribund patient- 73 (19%) .
This rather arbitrary grading of tracheostomies emphasizes the value of the operation and justifies, in part, the present enthusiasm for it. However, it should be remembered that almost half the complications were infective in origin and onequarter were due to loss of a patent airway through the tracheostomy tube. In addition, many of the complications occurred in the first 48 The beta-haemolytic streptococcus has not shown the same ability to produce antibiotic-or chemotherapeutic-resistant variants as Staphylococcus aureus. In the past, however, it has shown a capacity to produce variants resistant to sulphonamide, notably in a plastic surgery unit where sulphonamide powder had been used prophylactically (Francis, 1942) , and in naval establishments where a few types, after becoming resistant to sulphonamide, became predominant in populations receiving prophylactic sulphadiazine (U.S. Navy Epidemiology Unit, Number 22, 1945 ; Damrosch, 1946) . None of these strains had lost their pathogenicity. Sulphonamide-resistant group A streptococci have been described in a civilian population in New York State (Johnson and Hartman, 1947) . The advent of penicillin reduced the importance of such strains, and indeed seemed almost to banish the beta-haemolytic streptococcus from Britain for many years. A survey of the antibiotic sensitivities of pathogenic organisms isolated in a large English hospital from 1951 to 1956 does not mention the beta-haemolytic streptococcus, presumably because the numbers isolated were too small (Giles and Shuttleworth, 1958) , and this was my experience during the same period in Eastern Scotland. From November 1957 to April 1959 1,002 strains were isolated in the laboratories of the Northern Ireland Hospital Authority Laboratory Service (Mitchell, 1962) land and Wales. These isolations numbered from 569 to 213 a week (Report, 1957) . During this period, however, the streptococcus was still producing small outbreaks of infection in hospitals, but only 22 epidemics of more than four cases were reported to the Public Health Laboratory Service during the period 1955 to 1958 (Williams et al., 1960) . Those authors also give a list of references to these small outbreaks.
The administration of antibiotics, particularly of tetracycline, in the prophylaxis of rheumatic fever in penicillin-allergic subjects has been advocated (Hodes, 1959) , and long-term therapy with tetracycline for chronic bronchitis is effective just now (Murdoch et al., 1959 ; Francis et al., 1964) . This widespread use of tetracycline for respiratory infections and a noticeable increase in the numbers of beta-haemolytic streptococci being isolated, many of which were tetracycline-resistant in vitro, prompted the present communication.
Tetracycline-resistant streptococci have been reported from many parts of the world, notably in a special burns unit in England where a chlortetracycline-resistant group A streptococcus was observed to arise during the course of treatment (Lowbury and Cason, 1954) , and, again in the same unit, an atypical anaerobic form, designated AN, associated with tetracycline-resistance, was described (Lowbury and Hurst, 1956) . Of more serious import were an outbreak of pharyngitis in New Orleans due to a tetracycline-resistant variant (Mogabgab and Pelon, 1958 ) and a report of tetracycline failure in the treatment of streptococcal pharyngitis due to tetracyclineresistance in New York (Stillerman et al., 1960) . The presence of tetracycline-resistant group A beta-haemolytic streptococci was reported in the general population of Seattle (Kuharic et al., 1960) , in New York (McCormack et al., 1962) , and in Victoria, Australia (Lane, 1962) . Their presence in widely separated areas of Great Britain was also recognized at this time (Parker et al., 1962 A similar breakdown of isolations from material sent by general practitioners (197 strains) and from ward patients (289 strains), out-patients (199 strains), and nurses (44 strains) showed the practitioner material to contain 41.5% resistant strains, the ward patients 31 %, the out-patients 23 %, and the nurses 20.5%. (Report, 1957) . This increased incidence of streptococcal infections may be partly due to the use of tetracycline for respiratory-tract and ear infections as a safe, easily administered broad-spectrum antibiotic without confirmation that the causative organism is sensitive to the drug, or that, once the patient has recovered, it has been eliminated from the site of infection. It has now been clearly established that, in Southern England, one-third of haemolytic streptococci are resistant to tetracycline.
It would appear from a rapid examination of the above data that tetracycline-resistant beta-haemolytic streptococci are more commonly seen in general practice than in hospital and among hospital staff, but the findings are considerably weighted. Only one-quarter of the strains came from general practice, and these contained nearly all those from ear infections (34 out of 47), the source with the highest incidence of resistant streptococci.
In contrast, only a few strains came from sputa from generalpractitioner sources (4 out of 155), and sputa had the lowest proportion of resistant strains. Many patients were treated with tetracycline before arriving in hospital, and this probably caused an increase in the number of resistant strains in the material from hospital sources. Tetracycline is inferior to penicillin in eradicating streptococci from the throat (Stillerman et al., 1960) , and would appear to be less effective in eradicating them from other sites, such as wounds and abscesses. It is a bacteriostatic drug, while penicillin is bactericidal.
The facts indicate that tetracycline is unsuitable for use in beta-haemolytic streptococcal infections without bacteriological control, and that penicillin is the drug of choice. It could be argued that in the presence of a mixed infection including penicillinase-producing staphylococci the streptococci may be protected by the staphylococcal penicillinase. A cure rate of 95 % in five days has been claimed in cases of acute otitis media when using oral phenethicillin or intramuscular benzylpenicillin. The usual cause of failure was the presence of a penicillin-resistant staphylococcus, but phenethicillin cured some such infections, and in only one case of failure was a beta-haemolytic streptococcus isolated after treatment (Morrison, 1961) .
When patients are allergic to penicillin there are cogent reasons for using erythromycin.
Injections of benzylpenicillin give the highest blood levels of the drug, and, weight for weight, this form of penicillin is the most effective against sensitive organisms. Injections may prove inconvenient in general practice or when the patient is a child, but oral phenoxymethylpenicillin and phenethicillin are almost as effective against haemolytic streptococci (Garrod, 1960) , and are more active than propicillin or phenbenicillin (Bond et al., 1963) .
The relative absence (16%) of tetracycline-resistant streptococci from sputa is probably a reflection of the general recognition that penicillin is the drug of choice for pneumonia. Nearly all the sputa examined came from ward patients or out-patients who, under long-term supervision by the physicians, were likely to have been treated with penicillin, so preventing the production of tetracycline-resistant variants. The " long-term tetracycline " patient seems to be such an obvious source of tetracycline-resistant streptococci in the community that a survey of such persons while on no other antibiotic might reveal these organisms in the throat. The proportion of tetracyclineresistant strains in the general population is rising; no survey previous to 1963, however, has been reported from this country. It was 20% in Seattle (Kuharic et al., 1960) , 19% in New York (McCormack et al., 1962 ), 19% in Australia (Lane, 1962 , and 32% in Bristol (Mitchell and Baber, 1965) .
Summary
The incidence of beta-haemolytic streptococcal infections in South-west Essex is considerable and is probably rising. Thirtyone per cent. of the infections are due to tetracycline-resistant strains, and these have not lost their virulence. Resistant strains have not been frequently noted in sputa, but it is possible that the " long-term tetracycline " patient is a source of these strains in the community. It is fruitless to speak of " hospital " or " G.P." streptococci, as resistant strains are being produced in both types of practice and the proportion of such strains in the population in general is rising. Penicillin is the drug of choice for beta-haemolytic streptococcal infections, and oral penicillin is preferable to tetracycline if injections are inconvenient.
